The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Whole transcriptome analysis of tumors with discordant oncotype and MammaPrint results in the FLEX trial.
 
Matei P. Socoteanu
No Relationships to Disclose
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Agendia; Amgen; Aptitude Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Daiichi Sankyo; Eisai; G1 Therapeutics; Genentech; Gilead Sciences; GRAIL; Halozyme; HERON; Immunomedics; Ipsen; Lilly; Merck; Myriad Pharmaceuticals; Nektar; Novartis; Pfizer; Pharmacyclics; Pierre Fabre; Prime Oncology; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Syndax; Synthon; Taiho Oncology; Takeda
Consulting or Advisory Role - Abbvie; Agendia; Amgen; Aptitude Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Daiichi Sankyo; Eisai; G1 Therapeutics; Genentech; Gilead Sciences; GRAIL; Halozyme; HERON; Immunomedics; Ipsen; Lilly; Merck; Myriad Pharmaceuticals; Nektar; Novartis; Pfizer; Pharmacyclics; Pierre Fabre; Prime Oncology; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Syndax; Synthon; Taiho Oncology; Takeda
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer
Research Funding - Seagen (Inst)
Travel, Accommodations, Expenses - Abbvie; Agendia; Amgen; AstraZeneca; Celgene; Eisai; GRAIL; Ipsen; Lilly; Myriad Pharmaceuticals; Novartis; Pfizer; Puma Biotechnology; Roche; Sanofi; Seagen
 
Kent Hoskins
Employment - Lilly (I)
Research Funding - Abbvie (Inst); Merck Sharp & Dohme (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Pfizer (Inst)
Other Relationship - Agendia
 
Adam Brufsky
Consulting or Advisory Role - Abbvie; Agendia; Bayer; bioTheranostics; Coherus Biosciences; Coherus Biosciences; Daiichi Sankyo/Lilly; Eisai; Genentech/Roche; General Electric; General Electric; Gilead Sciences; Immunomedics; Lilly; Merck; Michael J. Hennessy Associates; Myriad Pharmaceuticals; Novartis; Onc Live; Pfizer; Puma Biotechnology; Seagen; Tyme
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst)
Expert Testimony - Pfizer
 
Cathy Lynne Graham
Research Funding - Agendia
 
Svetislava J. Vukelja
No Relationships to Disclose
 
Jamal Ghazi Misleh
No Relationships to Disclose
 
Karen L. Tedesco
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; Pfizer; Seagen
Speakers' Bureau - AstraZeneca; daiichsankyo; Gilead Sciences; Immunomedics; Merck
Travel, Accommodations, Expenses - Pfizer
 
Rakhshanda Layeequr Rahman
No Relationships to Disclose
 
June Lee
Speakers' Bureau - Agendia
Research Funding - Agendia
 
Julian Berrocal
Employment - HCA Healthcare
 
Kamal Sharma
No Relationships to Disclose
 
Albert Begas
No Relationships to Disclose
 
Jennifer Crozier
Research Funding - Agendia; CytomX Therapeutics; Merck; Roche; Seagen
 
Ian Grady
No Relationships to Disclose
 
Nina D'Abreo
No Relationships to Disclose
 
Midas M. Kuilman
Employment - Agendia
 
Holly Nguyen
Employment - Agendia
 
Lisa Eileen Blumencranz
Employment - Agendia
 
M. William Audeh
Employment - Agendia
Leadership - Agendia
Stock and Other Ownership Interests - Agendia
Consulting or Advisory Role - Celanese; Private Health
Research Funding - Agendia
Travel, Accommodations, Expenses - Agendia